fbpx
  • Home
  • Study Details
Not currently enrolling

Evaluation of Blood-Based Assay for Colorectal Cancer Screening

The purpose of the study is to see if a blood test called GuardantLUNAR-2 can help detect colorectal cancer or other diseases. The main goal of ECLIPSE is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to have a colonoscopy screening test.

Age & Gender

  • 45 years ~ 84 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Sarah McGill
Medicine-Gastroenterology

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Colorectal)

IRB Number

19-3521

ClinicalTrials.gov

NCT04136002

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research